Načítá se...
SC83288 is a clinical development candidate for the treatment of severe malaria
Severe malaria is a life-threatening complication of an infection with the protozoan parasite Plasmodium falciparum, which requires immediate treatment. Safety and efficacy concerns with currently used drugs accentuate the need for new chemotherapeutic options against severe malaria. Here we describ...
Uloženo v:
Vydáno v: | Nat Commun |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Nature Publishing Group
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5290327/ https://ncbi.nlm.nih.gov/pubmed/28139658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms14193 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|